Literature DB >> 33162564

Disease, downturns, and wellbeing: Economic history and the long-run impacts of COVID-19.

Vellore Arthi, John Parman.   

Abstract

How might COVID-19 affect human capital and wellbeing in the long run? The COVID-19 pandemic has already imposed a heavy human cost-taken together, this public health crisis and its attendant economic downturn appear poised to dwarf the scope, scale, and disruptiveness of most modern pandemics. What evidence we do have about other modern pandemics is largely limited to short-run impacts. Consequently, recent experience can do little to help us anticipate and respond to COVID-19's potential long-run impact on individuals over decades and even generations. History, however, offers a solution. Historical crises offer closer analogues to COVID-19 in each of its key dimensions-as a global pandemic, as a global recession-and offer the runway necessary to study the life-course and intergenerational outcomes. In this paper, we review the evidence on the long-run effects on health, labor, and human capital of both historical pandemics (with a focus on the 1918 Influenza Pandemic) and historical recessions (with a focus on the Great Depression). We conclude by discussing how past crises can inform our approach to COVID-19-helping tell us what to look for, what to prepare for, and what data we ought to collect now.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Early-life health; Human capital; Long-run effects; Pandemics; Public health; Recessions; Scarring

Year:  2020        PMID: 33162564      PMCID: PMC7606070          DOI: 10.1016/j.eeh.2020.101381

Source DB:  PubMed          Journal:  Explor Econ Hist        ISSN: 0014-4983


Introduction

The health and economic toll of the COVID-19 pandemic continues to expand throughout the globe, impacting countries both rich and poor. As it does so, the virus exposes the strengths and weaknesses of our healthcare systems, political institutions, media, and our economies themselves. Much of the discussion to date has understandably focused on stemming the immediate costs of the COVID-19 crisis: among them, mortality, business failures, job losses, and foreclosures. This pain is salient, and as such, very obviously demands an urgent response. However, there are potential outcomes of the current pandemic which, while perhaps less salient, also merit urgent attention: namely, long-run damage to human capital and wellbeing. It is to these particular long-run effects that we turn our attention in this paper.1 The potential for long-run harm to human capital arises from two main facts about the current pandemic. First, key features of COVID-19—among them its geographic reach, its relatively high ease of transmission, its comparatively low lethality, and its many emerging sequelae—have given rise to widespread and potentially lasting morbidity among its many survivors. Second, the pandemic has sparked an unprecedentedly large downturn, which in its own right has the capacity to permanently scar trajectories of health and income, even for those who do not fall ill themselves. While the costs of these long-run effects may seem far away, they are latent today and could become massive down the line: burdening healthcare systems and government assistance programs, suppressing work capacity and human capital investment, and reducing economic prosperity more generally. Luckily, the returns to avoiding these harms, or to acting swiftly to compensate for them before they have a chance to compound, tend to be much higher the sooner interventions can be made (see, e.g., Heckman, 2007; Almond and Currie, 2011). Together, the potential for diffuse and latent adverse effects, and the cost-effectiveness of early remediation, suggest that in addition to any efforts to address the immediate pain of the pandemic, our eyes should also be on the future—and on actions we can take now to mitigate the long-run pain for affected cohorts, and therefore, the wider economy. But what, exactly, is the long-run human fallout of COVID-19 likely to be—and who will bear the brunt of this crisis? To answer these questions, we need the sort of long-run view that only history can provide. An obvious starting point is to look to evidence from historical pandemics. Despite potential differences in empirical settings and epidemiological characteristics, the sheer number and diversity of past pandemics means that COVID-19 has many close historical analogues as a health crisis. For instance, while the current pandemic is frequently described as unprecedented, in many ways, its immediate effects on health are not altogether anomalous. With cases first appearing in December 2019, SARS-CoV-2, the pathogen behind COVID-19, spread throughout the world in a matter of weeks, with deadly consequences. By the end of April 2020, worldwide cases had topped 3 million, and fatalities exceeded 200,000. As of this writing in late October 2020, and with the pandemic still spreading, cases exceed 43.8 million, and fatalities have surpassed 1.1 million.2 For context, deaths from H1N1 (swine flu) in 2009-10 were smaller in magnitude, with estimates of over 200,000 deaths attributable to the virus (Dawood et al., 2012). While at 1 million deaths, the Hong Kong Flu of 1968 is comparable to COVID-19 in its death toll to date, the Asian Flu of 1957 was substantially deadlier, killing 2 million people. Likewise, cholera, typhus, smallpox, measles, and tuberculosis all have had high death tolls, including during the 20th century. Reaching even further back, the Black Death left a devasting imprint on the world, killing a third of Europe's population.3 Clearly, historical pandemics offer a rich evidence base that can help shed light on the range of possible long-run effects of COVID-19 through morbidity and mortality. However, there is one crucial aspect of the current pandemic that sets it apart from all but the most catastrophic historical disease outbreaks4 : the presence of an acute public health crisis alongside massive and widespread economic disruptions. Not just that—it is the fact that this health crisis has precipitated an economic one. To wit, efforts to stop the spread of the virus, alongside failures to contain it, have contributed to a dramatic slowdown of the global economy. Consider, for instance, the economic dislocation experienced in the U.S., a country which quickly came to lead the world in both confirmed COVID-19 cases and deaths. In March and April of 2020, roughly 20 percent of the United States’ labor force filed unemployment claims. Double-digit unemployment would continue through the summer. The Dow Jones fell by over 35 percent. For contrast, during 1957 influenza pandemic, responsible for roughly 100,000 deaths in the U.S. (Glezen, 1996; Simonsen et al., 1997), unemployment peaked at 7.4 percent, and the Dow fell 15 percent—certainly a recession, but nothing on the order of what we have already experienced during the COVID-19 outbreak, just a few months in. The unprecedented scale of the COVID-19 economic downturn relative to past pandemics is apparent in Fig. 1 , which shows the evolution of U.S. GDP over time, with major epidemics highlighted.
Fig. 1

U.S. log real GDP per capita with major epidemics highlighted, 1790-2020

Notes: Annual GDP per capita data for 1790 through 2019 are taken from https://www.measuringworth.com. Quarterly real GDP per capita data for 2019 and 2020 are taken from https://fred.stlouisfed.org/series/A939RX0Q048SBEA and deflated to 2012 dollars to match the historical data. Code to generate the figure and the underlying data for it can be found at Open-ICPSR (see Arthi and Parman, 2020; https://doi.org/10.3886/E125441V1).

U.S. log real GDP per capita with major epidemics highlighted, 1790-2020 Notes: Annual GDP per capita data for 1790 through 2019 are taken from https://www.measuringworth.com. Quarterly real GDP per capita data for 2019 and 2020 are taken from https://fred.stlouisfed.org/series/A939RX0Q048SBEA and deflated to 2012 dollars to match the historical data. Code to generate the figure and the underlying data for it can be found at Open-ICPSR (see Arthi and Parman, 2020; https://doi.org/10.3886/E125441V1). Clearly, this feature of the current pandemic calls for complementary evidence if we are to understand its potential for long-run harm: there is no suitable all-in-one historical analogue for COVID-19, and evidence from past pandemics alone is likely to understate the potential for damage to (or intervention in) health and welfare through income and labor-market channels. Indeed, to continue with our U.S. example, the two-trillion-dollar Coronavirus Aid, Recovery, and Economic Security Act's closest comparison is not to be found in past responses to health crises, but rather in the response to past macroeconomic crises—e.g., the American Recovery and Reinvestment Act in the case of the Great Recession, and the New Deal in the case of the Great Depression. Federal outlays as a percentage of GDP rose from 3.3 percent at the start of the Great Depression to 9.8 percent by 1934. The CARES Act alone is equal to roughly 10 percent of 2019 GDP, and this does not account for additional relief that may be approved in the coming months.5 Asset purchases in response to the Great Recession increased the Federal Reserve's balance sheet from $0.9 billion in 2007 to $4.5 trillion in 2015. That balance sheet has gone from $4.2 trillion in February of 2020 to $7.2 trillion just four months later.6 By nearly any metric, COVID-19 has generated both an economic crisis and a government response of historic scale. Studying how individuals emerged from these primarily economic disasters, and what role government fiscal interventions played in their recovery, may therefore help us flesh out the incomplete perspective we would gain from studying past health shocks alone. Turning to a combination of historical crises, then—past pandemics and recessions, both—allows us to consider events that in many ways more closely mirror current circumstances, and whose contextual differences can themselves be informative of our current situation First, and most crucially, these events have had time to fully unfold: the short-, medium-, and long-run consequences of these events can be directly observed. Second, the diverse array of historical events, settings, and mechanisms provides a set of reasonable analogues for COVID-19, even as our understanding of COVID-19 evolves. Third, the economic history literature shows how much can be learned with clever analysis of even incomplete or imperfect data. The problem of missing and inaccurate health data is unfortunately directly relevant to assessing the spread of COVID-19, given, for instance, current issues with testing and coordination. Thus, a historical perspective allows us to use rich data to look at not only the short-term effects of crises like COVID-19 on health, labor, and human capital, but also the long-term and intergenerational impacts along these dimensions for both individuals and the wider economy. In so doing, it can offer us insight on the current crisis—telling us what to look for, what to prepare for, and what data we ought to collect now. Put another way, understanding the lingering health and economic impacts of these past crises offers valuable insight for anticipating and responding to the potential long-term effects of COVID-19. To examine how history can inform our view of the coronavirus pandemic and associated policy responses as they relate to long-run wellbeing, we begin in Section II by reviewing the features of COVID-19 that will determine its potential health and economic impacts, and placing these features in historical context. Then, in Sections III and IV, respectively, we narrow our focus to two of the closest analogues to the current pandemic—one, the 1918 influenza pandemic, which speaks to “direct” health-channel effects; and another, the Great Depression, which speaks to “indirect” effects through the labor market and wider economy. There, we review the economic literature on the short- and long-term effects on cohorts exposed to these massive shocks, and discuss how these short-run experiences can give rise to lasting, and sometimes hidden, damage. We conclude by discussing what economic historians and researchers of COVID-19 can offer each other.

Features of COVID-19 in historical context

Before we can look to historical evidence on how COVID-19’s effects may unfold in the long run, it is useful to fix ideas about key features of the current crisis—its epidemiology, its demographics, and the policy responses to date. Comparing these features to those seen in past pandemics offers a sense of which historical pandemics might serve as the most useful points of reference going forward.

The epidemiology of COVID-19

We draw here on the principles outlined by Morens et al. (2009) to categorize pandemics. They point to eight characteristics common to most accepted definitions of a pandemic: 1) wide geographic extension and 2) disease movement, which speak to the disease's spatial reach; 3) high attack rates and explosiveness, 4) infectiousness, and 5) contagiousness, which speak to how it spreads; 6) severity, which speaks to its potential for population scarring and culling; and 7) minimal population immunity and 8) novelty, which speak to the scope for harm and the speed with which preventive and therapeutic responses can be marshalled. By all measures, COVID-19 presents these hallmark features of a pandemic. Understanding exactly how COVID-19 reflects each dimension is essential for understanding the likely short- and long-run consequences of the pandemic.

Spatial scope: geographic extension and disease movement

The widespread nature of pandemics makes their health and economic impacts particularly devastating: with effects felt everywhere, it becomes increasingly difficult to shift economic activity to, or medical resources from, unaffected areas. While the true extent and timing of COVID-19 cases is yet to be determined, the evidence to date indicates that the global spread of the virus has been incredibly rapid. The earliest reported cases appeared in December 2019 in Wuhan, China. That same month, the virus made it to France. By January 2020, there were confirmed cases throughout Asia, Europe, North America, and Africa, and by the end of the month, the number of cases worldwide reached 10,000. In the months that followed, that number rose sharply—first to 85,000 in February, 750,000 in March, and over 3,000,000 by the end of April. By May 2020, only 12 sovereign states had no confirmed cases, 10 of which are island nations in Oceania. COVID-19 had become a truly global pandemic by the end of spring 2020, and both cases and fatalities have continued to rise across the globe in the months that followed.7 This feature of COVID-19 surely has much to do with the highly globalized nature of our modern economy. Indeed, we see similar patterns in historical pandemics, reaching as far back as we have had extensive trade routes.8 Nearly every country with reliable mortality statistics displayed excess deaths from the 1918 influenza pandemic (Barro et al., 2020). Similarly, the plague pandemic originating in Canton and Hong Kong in 1894 spread to 77 ports across five continents (WHO, 2000), and even the Justinian Plague of 542 reached Asia, Africa, and Europe. Even in a historical era where countries were less tightly integrated than they are today, the only thing that truly spared an area from pandemics was isolation.9 With the increase over the last few centuries in both global connectedness and population density, the implications for our current crisis are clear.

Rate of transmission: attack rates, explosiveness, infectiousness, and contagiousness

The speed with which a disease spreads directly impacts the difficulty of containing it. Indeed, it is these transmissibility-related features that account for many of the public health measures seen in response to the current crisis—some, such as early international travel restrictions, which tried to contain a disease that in many countries was already being spread locally via community transmission; and some, such as stay-at-home orders and mask-wearing, which have been more effective in slowing transmission once it was too late for a containment strategy to be tenable. High attack rates and explosiveness (multiple cases appearing in a short time span) make it hard to stay ahead of a disease. These characteristics are functions of a disease's infectiousness and contagiousness: its ability to spread from person to person. COVID-19 is transmitted by respiratory droplets and aerosols produced when an infected person coughs or sneezes. This has led to COVID-19 having a daunting rate of transmission, with early estimates of a basic reproductive rate of between 4 and 9 (Sanche et al., 2020).10 As a point of reference, these transmission numbers are akin to those seen for past SARS, polio, mumps, yellow fever, and 1918 influenza outbreaks (see Fig. 2 ). The economic history of these pandemics thus provides a guide for what we might expect from the COVID health crisis. For contrast, the economic history of measles—which presents far higher transmission rates, with estimates of basic reproductive rates greater than 10 (Guerra et al., 2017)—offers a sense of how much worse things could be.
Fig. 2

Case fatality rate as a percentage by basic reproduction rate for various diseases

Notes: Case mortality rates are for untreated patients. For COVID-19, basic reproduction rates are taken from https://wwwnc.cdc.gov/eid/article/26/7/20-0282_article. All other reproduction and fatality rates are taken from https://docs.google.com/spreadsheets/d/1kHCEWY-d9HXlWrft9jjRQ2xf6WHQlmwyrXel6wjxkW8/edit#gid=0 (the data underlying https://www.theguardian.com/news/datablog/ng-interactive/2014/oct/15/visualised-how-ebola-compares-to-other-infectious-diseases), accessed on June 15, 2020. The code and data needed to generate the figure are available at Open-ICPSR (see Arthi and Parman, 2020; https://doi.org/10.3886/E125441V1).

Case fatality rate as a percentage by basic reproduction rate for various diseases Notes: Case mortality rates are for untreated patients. For COVID-19, basic reproduction rates are taken from https://wwwnc.cdc.gov/eid/article/26/7/20-0282_article. All other reproduction and fatality rates are taken from https://docs.google.com/spreadsheets/d/1kHCEWY-d9HXlWrft9jjRQ2xf6WHQlmwyrXel6wjxkW8/edit#gid=0 (the data underlying https://www.theguardian.com/news/datablog/ng-interactive/2014/oct/15/visualised-how-ebola-compares-to-other-infectious-diseases), accessed on June 15, 2020. The code and data needed to generate the figure are available at Open-ICPSR (see Arthi and Parman, 2020; https://doi.org/10.3886/E125441V1).

Pandemic severity

Like the disease's ease of transmission, the severity with which it manifests symptoms will also be a crucial determinant of both its consequences for individuals and the wider economy, and the nature and magnitude of the government response. For instance, a highly lethal pandemic may generate extensive and indiscriminate mortality; a less lethal pandemic may generate culling (selective mortality related to a specific health threshold); and an even less lethal pandemic may generate very little mortality, but substantial health scarring among survivors. If a disease is so mild that many of those who are infected remain asymptomatic, this can, in the absence of widespread testing, undermine efforts to slow transmission. Likewise, rates of infection, in combination with severity considerations, will help determine whether governments intervene, or merely wait for the disease to “take its course” on the way to achieving herd immunity. In its April 14, 2020 COVID-19 Strategy Update, the World Health Organization note that 40 percent of those infected experience moderate disease, including pneumonia, and 15 percent experience severe disease. They cite a crude clinical case fatality rate of over three percent that rises to 15 percent or higher in individuals over the age of 80.11 As shown in Fig. 2, the crude mortality rate for COVID-19 in its first months is similar to that of the 1918 influenza pandemic and of measles, but far lower than the deadlier recent outbreaks of MERS, Ebola, SARS, and lower still than the truly devastating historical toll of smallpox, which had an average case fatality rate of 30 percent (Ellner, 1998). This rich historical spectrum of pandemic severity, in turn, demonstrates that both mild and severe diseases impact the economy, albeit in very different ways. For instance, the eradication of hookworm in the U.S. South—a disease which is not fatal, but which primarily causes lethargy and anemia—improved returns to schooling, educational attainment, and incomes in areas with high prior infection rates, but did little to change to overall demographic, economic, or institutional structure (Bleakley, 2007). For contrast, the Black Death and other pre-modern outbreaks of plague, which had extraordinarily high death tolls, fundamentally reshaped the global economy through their effects on population size and demographic structure.12 In this context, COVID-19’s wide scale and relatively low lethality will surely have a bearing on the scope, magnitude, and timescale of damages. As we will see in later sections, it suggests that we might ultimately expect to see the greatest harm only in the long run, with widespread generational scarring arising from short-run morbidity and economic disruptions.

Population immunity and novelty

The novelty of a pandemic virus contributes to its potential for destruction: it takes time to identify a new disease, understand key features of its epidemiology, develop treatments and vaccines, and achieve a degree of population immunity. In the meantime, everyone represents a potential disease vector and a potential victim. As a novel coronavirus, COVID-19 struck a population with neither natural nor acquired immunity: wherever the virus spread, it had the potential to be devastating. With little immediate means of preventing, testing for, or treating it, some of the only short-run mitigation strategies available have been relatively brute-force ones such as lockdowns and border closures. Consequently, economic shutdowns—resulting both from official government actions and from individuals taking actions to avoid exposure—have been widespread, leaving no major economies or populations spared. Interestingly, because medical technology was limited for much of the past, and societies could only count on some degree of population immunity, even endemic (i.e., non-novel) diseases could have the sort of destructive potential we typically only see today in new disease variants such as the novel coronavirus.13 For instance, in a variety of past pandemics studied by economic historians, cases of an endemic disease would sporadically rise sharply, with substantial consequences for living standards and economic organization. Indeed, a large literature considers the impact of such diseases on the growth trajectories of countries over the long run, often focusing on tropical diseases like malaria, yellow fever, dengue, and others. One strand of studies considers the direct impact of disease on human capital formation (see, for example, Bleakley (2003, 2010) on malaria). Another strand focuses on the impact of these endemic diseases on institutional development, finding that disease environments inhospitable to colonial settlers drove them to rely on extractive institutions that were ultimately harmful to economic growth (Acemoglu et al., 2001). Finally, scholars have considered the way that one society's acquired immunity to an endemic disease can devastate the economy of another society lacking that immunity (Diamond, 1999; McGuire & Coelho, 2011; Tang, 2017). Together, this historical evidence gives us a picture of what our circumstances might look like today if we are unable to adequately ramp up our capacity for disease prevention and treatment, and are instead forced to rely on acquired immunity, the nature of which for COVID-19 is still poorly understood.

Demographics and distributional effects

Age has been at the forefront of discussions about the disparate impact of the current crisis, and shutdown efforts have been framed in part around protecting older individuals and other vulnerable populations, such as the immunocompromised, while societies work to expand medical capacity and develop a vaccine. In this respect, COVID-19 is much like many infectious disease outbreaks in the past—though young people can both transmit the disease and become ill, it is the elderly and those with poor baseline health that are at greatest risk. CDC estimates put the risk of hospitalization five times higher, and the risk of death from COVID-19 90 times higher, for 65–74 year-olds compared to individuals in their twenties.14 Likewise, despite claims in some quarters that COVID-19 is “the great equalizer,” it is already becoming clear that socioeconomic status will be central to understanding the demographics of this crisis. One of the ways low-income populations will be affected is through differential exposure to pandemic risks.15 Individuals who continue to do their jobs in person during the pandemic—including service-industry workers with extensive contact with customers, healthcare professionals, and other frontline workers—will bear a disproportionate burden of the pandemic's health impacts. These workers are more likely to be in low-paying jobs, and are more likely to be women and minorities, than their counterparts with jobs allowing them to work from home. Consider, for instance, meat and poultry workers in the U.S. The mean annual wage in the industry is only $28,000.16 Among laborers in the food manufacturing industry, 27 percent are black and 40 percent are Hispanic.17 Three-quarters of full-time, year-round healthcare workers are female, with that share even higher among the lower-paid nursing and health aide occupations, critical occupations with severe risk of exposure to COVID-19.18 This disproportionate exposure to virus for lower income groups, women, and minorities is exacerbated by differences in these groups’ access to healthcare and the quality of that health care—factors that affect both vulnerability and resilience to pandemic disease. Membership in more than one of these groups will tend to compound disadvantage even further. Preliminary research suggests that black patients exhibiting COVID-19 symptoms were six times less likely to get treatment or testing than white patients.19 This is not unique to COVID-19: similar patterns have been observed for other modern pandemics including the H1N1 influenza outbreaks (Quinn et al., 2011). The outsized impact of pandemics on minority populations and people of lower socioeconomic status has historical precedent.20 The 1918 influenza pandemic hit the poor first and hardest (Sydenstricker, 1931; Mamelund, 2018), a point we will return to in Section III. Explanations for this relationship mirror modern ones: poorer populations lived in denser housing units under worse conditions, and had occupations that increased exposure to the virus.21 Moreover, low incomes and institutional barriers alike constrained the ability of disadvantaged groups to avoid exposure and seek treatment.22 On the latter point, for instance, and drawing on new data from South Africa during the 1918 influenza pandemic, Fourie and Jayes (2020) suggest that pre-existing racial disparities in access to healthcare were responsible for disparities in influenza mortality across communities with higher and lower shares of black residents, and that the pandemic only served to widen prior racial disparities in health. On the former point, historical evidence shows that to escape a 19th century outbreak of yellow fever, wealthier residents often left the city—an option unavailable to low-income workers with tenuous job security. This is a pattern that we see as well during outbreaks of plague in earlier centuries, and is part of Dittmar & Meisenzahl's (2017) explanation for why the Black Death paved the way for institutional reform: the old elites simply left town (Dinges, 1995; Isenmann, 2014). This sort of regional flight is unlikely to be a central dimension along which COVID-19 has differential impacts across income levels—but it does raise important issues that set the current crisis somewhat apart from other historical pandemics: the spatial distribution of population within and across cities, the degree of interconnection between rural and urban areas, and the extent of urban health penalties. While cities are much healthier today than in the past,23 societies today are also much denser, more urbanized, and better connected—all factors that would tend to make modern pandemics both faster to spread and harder to control than in centuries prior. And indeed, while COVID-19 has hit dense metropolitan areas particularly hard, as in the past, under the current crisis, rural communities have not been spared. This is in part because of the relative ease with which people circulate between communities with our modern transportation networks, but also because of the way that the nature of modern work tends to place individuals in close contact with each other, even in less densely populated areas. To wit, major rural clusters of COVID-19 in the United States have been tied to large meat and poultry processing facilities, with workers at these facilities experiencing case rates an order of magnitude higher than the general U.S. population (Dyal et al., 2020). Moreover, rural areas’ demographic composition (often older and less affluent) and healthcare infrastructure (often sparser) can also contribute to their difficulties with pandemic disease. To respond effectively to pandemics in the moment, and to deal with their long-run fallout, will require an understanding of its distributional effects over time and space. We explore these central considerations in depth in Section III.

Policy response

Evaluating the policy response to COVID-19 and how it compares to historical pandemics requires recognizing that information on the disease and how to stop its spread has been limited to date, and is still evolving.24 This issue stems in part from COVID-19 being a novel disease—developing treatments and vaccines takes time, and public health recommendations can change as knowledge advances. It also stems from incomplete and inaccurate data: limitations on COVID-19 testing has often meant relying on mortality rates rather than case rates. Incidentally, this is the same approach economic historians are often required to take. Morbidity data are rare historically and, when available, may be unrepresentative and inaccurate. Mortality data are both far more prevalent and reliable, even if it is morbidity that is typically more relevant to the economic impacts of a pandemic, particularly less lethal ones. For health officials today, the need to assess the spread of COVID-19 through mortality data leads to the frustration of identifying the arrival of cases with a substantial lag. For the economic historian, this lag is irrelevant, but the issue remains that only those places experiencing excess mortality can be identified; diseases leading to widespread morbidity but little mortality may be equally important for the evolution of economies, but far more difficult to identify prior to modern medical records. Again, this suggests that evidence from crises that have run their course can be informative of what to expect going forward. While some of the challenges in developing effective COVID-control responses have stemmed from incomplete and rapidly evolving knowledge of the disease, they have also stemmed from issues of state capacity, political will, and ideology. For instance, policymakers, firms, and individuals have been hamstrung by not only limited testing and contact tracing capacity, but also by a failure at times to deploy these tools efficiently. Constraints such as these are a product of both the limitations of medical technology, and broader issues of political leadership and coordination. The inability to identify and isolate individuals at risk of spreading the disease, in turn, has necessitated rather blunt policy tools, such as business closures and stay-at-home orders. In the U.S. in particular, these COVID-control efforts have been aggressively decentralized, and have tended to prioritize both commerce and individual liberty—even where these might be at odds with each other, or lead to ineffective disease control.25 To wit, business owners and public officials have struggled to gain widespread compliance with (and have often declined to enforce) precisely the sorts of behaviors—e.g., mask-wearing, social distancing—that would allow for the safe reopening of businesses. Indeed, it appears that the fear and uncertainty created by the failure to control the spread of disease, in turn, has contributed to prolonging economic pain (Goolsbee and Syverson, 2020). Challenges such as these, related to culture and institutions, are nothing new—in fact, they characterize the U.S.’s historical experience of managing epidemic disease. In his excellent The Pox of Liberty, Troesken (2015) lays out how the very institutional features—among them a decentralized federal system, a focus on property rights and commerce, and protection of individual liberties—that led to the U.S.’s rapid economic development also often undermined its attempts to control past outbreaks of smallpox, typhoid, and yellow fever. The examples he provides have uncanny parallels to the U.S.’s approach so far to managing COVID-19. Strategies to manage the spread of COVID-19 have been varied, with many jurisdictions pursuing multiple complementary approaches, often including coordinated sourcing and distribution of protective equipment, reallocation of medical capacity, virus and antibody testing, contact tracing, frequent sanitizing of public facilities, social distancing, mask-wearing, managing congestion in public places by staggering timings and moving activities outdoors, limiting large gatherings, quarantining infected individuals, and minimizing the risk of disease exposure by way of school and business closures and broader stay-at-home orders. Of these strategies, shutdowns and quarantines have been some of the most accessible, widely used, and hotly debated under COVID-19. A shutdown-centered approach such as this also has strong historical precedent. In fact, closures and quarantines were some of the only tools available to societies prior to the virology advances of the 19th and 20th centuries. Though the shutdown of firms has been more comprehensive under COVID-19 than in many past pandemics,26 the primary measures being taken now, such as quarantining sick individuals, restricting public gatherings, and closing schools, were all implemented during the 1918 pandemic (Markel et al., 2007; Hatchett et al., 2007), albeit with a smaller scope and shorter duration.27 Likewise, when England was combatting the plague in the 1600s, they quarantined ships from other countries, closed ale houses, and limited the number of lodgers allowed in a house, actions that would sound familiar to cruise ship passengers and restaurant owners during the COVID-19 pandemic (Bell, 1924). Indeed, it is striking—maybe even alarming—how little has changed about our best options for fighting pandemics, despite centuries of advances in medicine, public health, and living standards. This policy response, necessitated by factors including inadequate testing and broader uncertainty about key epidemiological parameters—even those as basic as precisely how and through whom the disease can be transmitted, and whether it is possible to become re-infected—makes the economic history of policy responses to pandemics particularly relevant for studying the current crisis.28 Even when we contemplate a world where successful COVID-19 vaccines are available, history sounds a note of caution: the same underlying issues that have made mask-wearing both incomplete and fraught in settings, like the U.S., with a strong institutional commitment to liberty and a culture of rugged individualism, could also be expected in the context of COVID-19 vaccination. As Troesken (2015) notes, anti-vaccinationism has a long history in the U.S., bolstered by the common failure to appreciate the extent of infectious-disease externalities (the choice not to vaccinate can be individually rational, even if people understood externalities, which they largely do not), as well as by a belief in both minority rights (individuals cannot be forced to vaccinate) and federalism (individuals preferring not to vaccinate can sort into amenable jurisdictions).29 While Troesken documents that mandatory vaccination was frequently enforced in the past via fines,30 or by denying access to schools or other public services, it is difficult based on the nature of the U.S. COVID-19 response to date to imagine such enforcement mechanisms being implemented. Instead, in heterogeneous, strongly pro-individual, pro-freedom societies, we may need to rely on a stylized fact that Troesken demonstrates using data from 19th century smallpox epidemics in Germany: vaccinations rates rise in pandemic years, because during pandemics, the risk of infection rises sharply, and the private costs of non-vaccination are clearly outweighed by the private benefits.

Consequences for wellbeing through the health channel: the 1918 influenza pandemic

For thinking about the direct effects of pandemics on the health and wellbeing of individuals in the short- and long-run, the 1918 Influenza Pandemic, or the “Spanish Flu,” provides a useful point of reference. COVID-19 to date parallels the 1918 pandemic in several key ways, including its rate of transmission, global spread, and crude mortality rates.31 The Spanish Flu was one of the most acute and widespread natural disasters in modern history. Taubenberger and Morens (2006) estimate that during the pandemic, roughly 500 million individuals, equivalent to roughly a third of the world's population at the time, were infected and symptomatic. Case fatality rates, at over 2.5 percent, were at least 25 times as high as in other influenza pandemics, making the 1918 virus especially lethal. All told, somewhere between 50 and 100 million individuals perished globally. The death toll in the U.S. alone exceeded that from all American combat deaths over the twentieth century (Almond, 2006). The pandemic itself was sharp, sudden, and concentrated over the span of little more than a 12-month period. The virus, an H1N1 strain similar to that which caused the 2009 swine flu outbreak, spread roughly simultaneously across Europe, Asia, and North America, in three distinct waves over the year beginning in spring 1918. The first of these waves, appearing in March 1918, was relatively mild. It was followed by a substantially more catastrophic one from September to November 1918, and another in the early months of 1919 (Taubenberger and Morens, 2006). In some parts of the world, particularly in East Asia, a further major wave of pandemic influenza hit as late as 1920 (Lin and Liu, 2014; Ogasawara, 2018). This sort of timing and spacing was unprecedented among influenza pandemics, as was its distinctive mortality profile. Where influenza death rates by age typically follow a U-shape, with high mortality rates among the very young and the very old (as is also the case with the SARS-CoV-2, the virus behind COVID-19), the 1918 strain followed a W-shape, with a sharp peak in mortality risk among young adults as well.32 Indeed, almost half of all influenza-related deaths during the pandemic period accrued to those aged 20-40 (Taubenberger and Morens, 2006). The age pattern associated with this strain of influenza was in fact so unusual that it has been exploited as a diagnostic tool in recent studies. For instance, while the 1918 influenza pandemic is typically thought to have emerged in full force in Europe around the summer of 1918, and in a milder form somewhere in the central U.S. in spring 1918, detailed age-by-month mortality statistics allow Olson et al. (2005) to uncover evidence that an early “herald” wave of pandemic influenza was actually present in New York City well beforehand, from February to April of 1918. During this period, the age profile of excess influenza mortality had started to shift from the older ages typical of interpandemic seasons to the younger ages that characterize pandemic seasons. This underscores the value of accurate and disaggregated data in tracing the origins and spatiotemporal spread of pandemics, and the need to strengthen not only rapid-response public health infrastructure, but also that to support ongoing disease surveillance. Turning to morbidity, those under the age of 35, and particularly, those aged 5-14, had disproportionately high incidence of influenza—however, the latter group had a much lower death rate from influenza and pneumonia than other ages, further sharpening the middle peak in the morbidity-adjusted pandemic mortality curve (Taubenberger and Morens, 2006). Age, however, was not the only major factor that contributed to pandemic mortality risk, and a range of recent studies have emerged cataloging the often interrelated features of countries, cities, and individuals that led to disparities in the immediate mortality burden of the 1918 flu.

Short-run mortality effects and mechanisms

On these mechanisms, the evidence is mixed—surely in part because of diverse empirical settings and disciplinary approaches—but certain patterns do nevertheless emerge. First, baseline health status mattered: both pre-pandemic pneumonia, a bacterial condition with a strong biological interaction with the influenza virus, and infant mortality rates, a proxy for population health, contributed to higher pandemic flu mortality (Acuna-Soto et al., 2011; Clay et al., 2019). Likewise, high levels of air pollution, an environmental factor that aggravates respiratory conditions and depresses baseline health, also raised pandemic mortality. For instance, Clay et al. (2019) examine evidence from a panel of 438 U.S. cities, and find that the air pollution generated by coal-fired electricity plants was a significant contributor to pandemic mortality, with effect sizes roughly half those associated with measures of population health and poverty.33 Together, they estimate that these factors accounted for approximately half of all cross-city variation in pandemic mortality. In another study, they find that both infant and all-age mortality were impacted adversely by the presence of coal-burning plants, with poor air quality responsible for 19-26 percent of total pandemic mortality in high- and medium-pollution cities, a figure equivalent to some 30,000-42,000 excess deaths beyond those attributable to the pandemic alone (Clay et al., 2018).34 , 35 Second, population density and related concerns, such as housing quality and the number and composition of social interactions, were also important factors in pandemic mortality. In Europe as in the U.S., the pandemic came to cities earlier, and was more devastating there, a phenomenon linked to urbanization and residential crowding (Chowell et al., 2008; Mamelund, 2006; Murray et al., 2006). Transmission was localized, and influenza and pneumonia mortality exhibited significant and rather tight (e.g., 200-1,500 m) spatiotemporal clustering (Grantz et al., 2016a,b; Tuckel et al. 2006), though proximity to high-risk population centers like WWI military bases appears to have had little effect (Clay et al., 2019). Although urban centers were associated with higher pandemic mortality, the opposite population gradient prevailed when comparing among cities, or among rural areas: in both cases, smaller, less dense localities fared worse (Acuna-Soto et al., 2011; Chowell et al., 2008), suggestive perhaps of capacity constraints in the healthcare workforce and medical infrastructure. Third, factors—such as illiteracy and foreign-born status—that might have prevented individuals from adopting public health recommendations were strong predictors of elevated mortality, often above and beyond their association with poverty.36 Higher rates of illiteracy were linked to higher rates of influenza mortality during the pandemic, across both cities and neighborhoods (Clay et al., 2019; Grantz et al., 2016a, b). Likewise, foreign-born status not only predicted higher pandemic mortality in Hartford, Connecticut, but the relationship between nativity and mortality persisted even after controlling for socioeconomic status, population density, and neighborhood ethnic composition, indicating perhaps a role for social factors, or language or cultural barriers to the adoption of relevant public health measures (Tuckel et al., 2006). Crucially, the consequences of these barriers were not limited to the foreign-born: holding all else equal, native-born individuals living in areas with a higher share of foreign-born had higher mortality rates than their counterparts living alongside a lower share of foreign-born neighbors. This emphasizes the importance of neighborhood spillovers in infectious disease transmission—and, of course, demonstrates the interrelated nature of individual- and neighborhood-level mechanisms. When considering these biological, demographic, and socioeconomic factors in quick succession, it is difficult not to see the overarching hand of income in all of these mechanisms—though, to be clear, several of these studies are careful to disentangle these factors from their association with income. In theory, income gradients in pandemic mortality could arise through a number of channels, including many of those hinted at above: e.g., the tendency of those with higher incomes to have better baseline health status, rendering them biologically less vulnerable and more resilient to infection; higher-quality and lower-density housing, reducing the chances of viral transmission; better public health knowledge, the human capital necessary for individuals to effectively assimilate this knowledge and to adopt life-saving recommendations, and timelier and more robust public health interventions, all slowing the spread of illness; better access to healthcare and medical infrastructure, improving the probability of survival conditional on infection; and a greater capacity for individuals to undertake avoidant, adaptive, and compensatory behaviors, both throughout and following the pandemic. Crucially, these channels can operate at both individual and institutional (e.g., city or country) levels, with both richer people and localities—and certainly, the interaction of these—theoretically better equipped to weather the crisis. The fact that some of these channels are highly correlated, of course, can make it difficult to pinpoint the underlying mechanisms: higher-socioeconomic status (SES) individuals are likelier to be both healthier, protecting them from infection, and more educated, rendering them better able to adopt public health measures; cities tend to be richer in both income and infrastructure, but they are also more heterogeneous and densely populated than rural areas. Nevertheless, the literature can still shed light on the role of income on net. While some studies explicitly looking at its role in pandemic severity have shown little relationship between pre-1918 economic development and pandemic mortality (Brainerd and Siegler, 2003), a great many indicate that poverty exacerbated mortality risk. For instance, Murray et al. (2006) document tremendous (i.e., over thirty-fold) within- and cross-country variation in excess mortality due to the 1918 pandemic, with nearly half of this variation explained by baseline per capita income. Taking a finer-grained look at these issues, Grantz et al. (2016a,b) explore the socioeconomic determinants of pandemic mortality and transmissibility using detailed data from Chicago. Among the associations they find between health and various poverty proxies are large, statistically significant, and negative associations between census tract-level homeownership rates and mortality. These findings are consistent with the lower baseline health of lower-SES neighborhoods, their poorer access to medical care, and their lower awareness and adoption of public health recommendations. Shanks and Brundage (2017) add that these factors may be proxying other features of low-SES populations, such as a higher risk of sequential infections (e.g., pandemic influenza followed by a secondary bacterial infection such as pneumonia), or the larger number and lower-SES composition of their social interactions. All of these could have contributed to higher cumulative pandemic mortality through faster and more widespread disease transmission, higher incidence of infection, or higher case fatality rates. These results suggest that rather than acting as a democratizing force, the pandemic further entrenched preexisting socioeconomic disparities. The clear implication of studies documenting the immediate health effects of the 1918 outbreak is that the damage from pandemics has, and remains likely to, fall disproportionately on disadvantaged communities.

Demographic effects

Apart from its effects on health, however, the pandemic also had important consequences for population dynamics. One such effect pertains to temporal and cross-disease mortality spillovers resulting from pandemic-era mortality patterns. Noymer (2011) shows that the 1918 influenza pandemic hastened the decline of tuberculosis in the U.S. through a harvesting mechanism. Specifically, he suggests that independent competing risks may be responsible for this phenomenon, driven by substantial age overlap in the profile of prospective tuberculosis and (pandemic-type) influenza victims. This “passive selection” contrasts with “active selection” based on biological interactions between influenza and tuberculosis. This harvesting, in turn, had long-lived implications for sex differences in post-pandemic mortality rates: because tuberculosis morbidity disproportionately affects men, and because the influenza pandemic reduced the pool of those who might die of tuberculosis in the years following, the pandemic had the effect of eroding women's longevity advantage over men. We might expect similar outcomes in the context of COVID-19 given that a large share of those dying have one or more co-morbidities, though the distinct age profile of 1918 pandemic deaths versus COVID-19 deaths may complicate these dynamics. Studying Brazil, Guimbeau et al. (2020) likewise find rather larger reductions in sex ratios at birth following the 1918 influenza pandemic, consistent with the greater vulnerability of male fetuses to adverse in utero shocks—a phenomenon often seen in the literature on famines and environmental disasters. Such changes in the sex ratio, or in sex-specific survival, may well have had long-run implications for marriage and labor markets. Another major area in which the pandemic affected demographic behavior relates to marriage and fertility. In some cases, this was largely a function of pandemic psychology. Mamelund (2004) shows that a climate of fear and uncertainty in 1918 Norway, alongside social distancing efforts and the peculiarities of Norwegian marriage laws (which imposed a one-year waiting period before widows could remarry), led to a drop in births in 1919, as families deferred childbearing.37 Higher rates of maternal mortality and miscarriage during the pandemic likely also contributed to a drop in birth rates. This pent-up demand for children (alongside “replacement” demand for children lost to the pandemic) was released after the crisis passed, resulting in a baby boom in 1920. Elsewhere, as was the case in nearby Sweden, changes in fertility arose from the way that pandemic mortality affected markets for marriage and labor: Boberg-Fazlić et al. (2017) find evidence of a drop in fertility during the pandemic, followed by a short-lived rebound in post-pandemic fertility. The net effect in the long term, however, was to reduce fertility—due in part to persistent disruptions to marriage markets (particularly in rural areas and poorer cities); the adverse effects on income; as well as to behavioral changes induced by the pandemic, including a rise in female labor supply (and so, an increase in the opportunity cost of childrearing) in regions with high male pandemic mortality rates. Perhaps most noteworthy, the short-run post-pandemic fertility increase was selective in nature: a child born during this boom was more likely born to mothers who were married or who were high-SES city-dwellers. This was largely driven by postponement fertility, and particularly, selective postponement.38 Finally, pandemic-related mortality affected childbearing through its effect on survivors’ incomes. Donaldson and Keniston (2014) show that the high pandemic death toll in some regions of India implied a substantial increase in per capita incomes, as survivors assumed the agricultural land of pandemic victims. In light of this rise in incomes, they find an increase in both the quantity and quality (given by literacy and height) of children born following the pandemic in India. Phenomena such as these, which change the sex- and age-composition of the population—not to mention the average health status of successive cohorts—are likely to have long-lived effects on economic development, population health, and individual wellbeing.

Long-run effects

The lethality and peculiar age profile of the 1918 pandemic also give rise to long-run considerations. These may be especially relevant in light of COVID-19, where the vast majority of people who become sick ultimately survive.39 During the 1918 pandemic, young adults—including prime childbearing-age women—were some of the likeliest to fall ill: in some parts of the U.S., roughly a third of all mothers (relative the about 28 percent of the general population) became infected during the crisis (Almond, 2006). Moreover, despite the very high mortality rates from this pandemic, most of those infected ultimately survived. This left considerable scope for maternal morbidity—and, through the impact of maternal stress and illness on intrauterine hormones, nutritional resources, and other factors—for insults to fetal health.40 In what is perhaps the seminal study in economics of the 1918 influenza pandemic's long-run effects on wellbeing, Almond (2006) finds wide-ranging adverse effects on later-life human capital and labor market outcomes among U.S. cohorts exposed to the pandemic in utero. These include substantial reductions in high school completion rates, wages, and socioeconomic status, alongside large increases in the probability of living in poverty, the receipt of welfare payments, the likelihood of incarceration, and—particularly among men—the probability of physical disability.41 That these adverse outcomes exist in spite of a pandemic-induced increase in miscarriages, stillbirths, and infant mortality rates (see, e.g., Guimbeau et al., 2020; Mamelund, 2004)—all culling forces which likely resulted in a pool of survivors if anything positively selected on health—is a testament to the catastrophic extent of post-1918 scarring. Almond's initial study has also since spawned a large and varied literature interrogating the long-run effects of the 1918 pandemic across a range of global settings. A first set of studies dig deeper into the U.S. case. One such study shows that 1919 birth cohorts (and in particular, those born in Quarter 2 of 1919, who were in utero at the height of the pandemic), are 4 percentage points (or 10 percent) more likely to report fair or poor health than their counterparts born in surrounding years; see a statistically significant 17-35 percent increase in a range of functional limitations, including trouble hearing, speaking, lifting, and walking; and are also likelier to experience diabetes and stroke (Almond and Mazumdar; 2005). Others debate the possibility of pandemic-induced selection into fertility, which could confound estimates of the long-run health effects of early-life pandemic exposure. These studies ultimately conclude that the positive selection of WWI recruits, and the corresponding negative selection of pandemic-era fathers, does not substantially alter the conclusion that fetal exposure to the 1918 pandemic was a major and direct cause of these cohorts’ later-life disadvantage (Brown and Thomas, 2018; Beach et al., 2018). A newer set of papers, focusing on non-Western, and particularly, lower-income, settings, shows that the evidence on the pandemic's long-run penalties is robust across a range of empirical contexts, each with different levels of baseline income and health status, different institutional responses to the pandemic, and different degrees of involvement in WWI. For instance, as in the West, in Taiwan there is evidence of permanent scarring: cohorts exposed to the pandemic in utero faced penalties with respect to educational attainment, heights, kidney disease, circulatory and respiratory issues, and diabetes (Lin and Liu, 2014). In low-income settings with minimal public health intervention, even higher incomes only did so much to buffer these shocks: in a sample of high-SES children in Japan, Ogasawara (2018) finds that in utero exposure to the 1918 influenza pandemic reduced boys’ and girls’ heights by 0.28 cm and 0.14 cm, respectively— magnitudes which in other studies have been associated with substantial increases in the probability of type II diabetes, osteoarthritis, and heart disease. The long-run results seen in Japan, as in Guimbeau et al. (2020) in Brazil, are consistent with sex differences in resilience to adverse health shocks. The reduction in the health, human capital, and labor market prospects of cohorts exposed in utero also appears to have dampened their marriage market prospects in ways that continue to carry intergenerational consequences. While both men's and women's own educational attainment was lower among exposed cohorts, only exposed women appear to have suffered a marriage market penalty: they married earlier, to spouses with lower levels of education (Fletcher, 2018). These are factors generally understood to reduce household incomes, female control of household resources, and the budget share allocated to child-centric expenditure. As such, these effects could represent a mechanism—alongside, e.g., epigenetics, or even the more direct role of parental education in facilitating children's access to quality healthcare and schooling—by which we see intergenerational persistence in the consequences of early-life exposure to the influenza pandemic of 1918. Indeed, moderate adverse effects on educational attainment, occupational prestige, and family socioeconomic status have been documented up to the third generation, i.e., the grandchildren of those exposed in utero (Cook et al. 2019). What action, if any, did households take to shield their children from these effects, or to help them recover? While surprisingly little has been written in the context of the 1918 pandemic on questions of individual- and household-level avoidance, adaptation, and remediation, Parman (2015) is a noteworthy exception.42 Drawing on linked microdata from the U.S., he finds evidence of reinforcing investments in response to the 1918 influenza pandemic: that is, families with a child in utero during the crisis shifted resources to the child's older siblings, leading the latter children to higher educational attainment. Parman explicitly rules out changes in family size, birth spacing, or selectivity in any such changes, underscoring that the effects observed here are directly a function of parents reallocating limited resources away from affected children, and toward the child with a higher human capital endowment at birth. Thus, household responses may have if anything compounded any early-life disadvantage associated with the 1918 shock.

Consequences for wellbeing through the economic disruption channel: the Great Depression and other historical downturns

Historical pandemics can help us think about potential long-run effects on wellbeing arising directly through the current pandemic's patterns of morbidity and mortality. But what about the impacts resulting from its disruption of daily economic life? One of the central features of the current coronavirus pandemic is the sudden, extreme, and widespread economic disruption it has caused. On this count, it has perhaps less in common with other recent pandemics. Indeed, the immediate economic disruption caused by the 1918 pandemic pales in comparison to that caused by COVID-19.43 So, while this historical pandemic can give us insight into long-run effects on wellbeing through the health channel (“direct” effects), we must look elsewhere to think about the long-run consequences of pandemics through corresponding economic downturns (“indirect” effects). But where to look for a suitable comparison? In some ways, episodes such as the Black Death or the AIDS crisis in Sub-Saharan Africa would seem to present closer analogues than the 1918 influenza pandemic, insofar as they too are health events with massive and lasting economic ramifications.44 The catastrophic loss of life under these pandemics fundamentally reshaped entire societies and economies, with, for instance, the resulting labor scarcity driving up the real wages of survivors, and, in some cases, precipitating other major demographic, economic, social, cultural, and institutional changes (Young, 2005; Alfani and Murphy, 2017). Indeed, some point to the former plague as a major contributor to sustained rises in Western European living standards even under a Malthusian regime (Voigtländer and Voth, 2009, 2013a,b), and to the region's rapid economic development and eventual divergence from the rest of the world over the early modern period (Clark, 2007). In each of these pandemics, mass mortality led to rapid and dramatic changes in population density and age structure, which in turn affected factor prices and labor markets. Thankfully, mortality rates under COVID-19 are not on such a scale as to produce the sort of fallout seen with these events.45 Instead, it appears it may be a combination of factors other than the virus's actual toll on morbidity and mortality that is the source of economic dislocation in this instance. Indeed, as Fig. 3 shows, the severity of the immediate health effects has not been a clear predictor of a locality's economic downturn. Likewise, emerging evidence complicates the popular conception that pandemic-control measures themselves, such as stay-at-home orders, are primarily responsible for the downturn associated with COVID-19. For instance, while Gupta et al. (2020) suggest that 60% of the decline in employment in the early months of the pandemic was driven by state and local social distancing policies, Kahn et al. (2020) show that the labor market effects of COVID-19 to date have been broader-based than is typically thought. All U.S. states exhibited a collapse in job vacancies in March 2020, and a corresponding rise in unemployment insurance (UI) claims, irrespective of either the intensity of the virus's initial spread or the timing of stay-at-home orders. These phenomena were seen for the most part across both essential and non-essential sectors, directly- and indirectly-affected sectors, and across occupations with and without work-from-home capabilities. They conclude that “the current damage done to the economy is not solely caused by the stay-at-home orders; it is too large and pervasive.” Exploring the drivers of the collapse in economic activity, Goolsbee and Syverson (2020) suggest that “individual choices were far more important [than government restrictions,] and seem tied to fears of infection.” These voluntary disease-avoidance strategies by individuals are likely connected to the lack of decisive and coordinated policy responses, and to broader uncertainty about this novel disease. It remains to be seen whether other plausible mechanisms may also have a role—e.g., global supply chains that allow COVID-related firm slowdowns in one country or sector to propagate to others, or changes in firm production decisions under COVID uncertainty.
Fig. 3

Unemployment rate and COVID-19 cases in the U.S. by state over time

Notes: The insured unemployment rate is based on employees covered under unemployment insurance as reported to states by employers. COVID-19 cases are relative to the entire state population. Unemployment data were retrieved from https://oui.doleta.gov/unemploy/claims.asp. COVID-19 data were retrieved from https://github.com/nytimes/covid-19-data. The code and data needed to generate the figure are available at Open-ICPSR (see Arthi and Parman, 2020; https://doi.org/10.3886/E125441V1).

Unemployment rate and COVID-19 cases in the U.S. by state over time Notes: The insured unemployment rate is based on employees covered under unemployment insurance as reported to states by employers. COVID-19 cases are relative to the entire state population. Unemployment data were retrieved from https://oui.doleta.gov/unemploy/claims.asp. COVID-19 data were retrieved from https://github.com/nytimes/covid-19-data. The code and data needed to generate the figure are available at Open-ICPSR (see Arthi and Parman, 2020; https://doi.org/10.3886/E125441V1). Clearly, both the current crisis and our understanding of it are still rapidly evolving. What we do know, however, is that the downturn this pandemic has precipitated is substantially larger than in other modern pandemics, and unlike in some pre-modern plagues, it is likely unrelated to either mortality-related changes in demography or to immediate reductions in labor supply or work capacity due to contemporaneous morbidity. As such, crises of primarily economic origin, such as historical recessions—and in particular, the Great Depression—may make the best analogues: while the coronavirus pandemic is a public health crisis, to be sure, it has manifested above all as a massive economic disruption, both in terms of magnitude and reach.46 Accordingly, we might want to think about its health and human capital consequences through this “livelihoods” channel as well. Indeed, it is these effects that are likely to be most relevant to our current situation.

Business cycles and health

Beginning with short-term effects, we can look to a large literature on business cycles and health. These studies indicate that the net effects of downturns on morbidity and mortality will likely be highly context-dependent. This is because health is multidimensional, there are many countervailing channels through which local economic conditions can affect wellbeing, and because the particulars of the empirical setting—e.g., the size, nature, and origin of the shock; the baseline level of population health; and the strength of social safety nets—will ultimately govern which of these effects dominate (Arthi et al., 2017; Cutler et al., 2016). Recessions have been shown to improve health, for instance, by freeing up time for health-promoting activities such as exercise, childcare, and breastfeeding (Dehejia and Lleras-Muney, 2004; Miller and Urdinola, 2010; Ruhm, 2000); by reducing the income available to sustain unhealthy behaviors such as alcohol, tobacco, and drug abuse (Ruhm and Black, 2002; Ruhm, 2005); by reallocating high-skilled but displaced healthcare workers toward higher-risk populations (Stevens et al., 2015); and by limiting individuals’ exposure to environmental and work-related hazards, including traffic accidents, on-the-job injuries, and pollution (Muller, 1989; Chay and Greenstone, 2003; Miller et al., 2009).47 Meanwhile, adverse income shocks can compromise access to basic needs such as nutrition, medical care, and housing (Griffith et al., 2013; Painter, 2010); and can cause psychological stress that in turn raises rates of self-harm and risky behaviors (Eliason and Storrie, 2009; Sullivan, Daniel, and von Wachter, Till., 2009).48 While in theory, the net effect of local economic shocks on health is ambiguous, in practice, the bulk of the evidence drawn from modern and rich-country settings suggests that on net, total mortality rates fall during recessions (Arthi et al., 2017). In addition to setting-specific features like higher baseline health and stronger safety nets, the fact that beneficial channels tend to dominate in these settings may be in part because this evidence comes principally from small fluctuations in local economic conditions: using cross-country evidence over two centuries, Cutler et al. (2016) show that mild downturns lower mortality, while large ones raise it.49 The downturn caused by COVID-19 would surely qualify as the latter. The evidence is much more mixed in developing-country and historical settings, where levels of baseline income and health are low, where safety nets are weak, and where cutting-edge medical technology is less accessible (see, e.g., Baird et al. (2011) and Ferreira and Schady (2009)). In such settings, even small losses in income can be devastating to health (Costa, 2015; Heckman, 2007), and there is less scope for the sort of offsetting positive spillovers and behavioral changes seen in more modern and affluent settings.50 Consequently, this evidence seems to more often indicate countercyclical mortality. For instance, Arthi et al. (2020a) show that even in the presence of adaptive migratory responses, the Cotton Famine, a major 1860s downturn in Britain's cotton textile-producing regions, substantially raised mortality in cotton regions, particularly amongst the elderly (who were more sensitive to income shocks), amongst cotton households (who faced unemployment and reduced hours), and amongst those working in non-tradeables (whose livelihoods depended on the success of the local cotton industry). Diverse historical evidence such as this can help us think about how the effects of the COVID-19 crisis might out play out differently in other economies, particularly in the long run—something we cannot get from modern data, and especially, from modern U.S. data, alone. Likewise, turning to the Great Depression, a more recent and thus perhaps more comparable setting to today's, Stuckler et al. (2012) find at best mixed evidence of a beneficial health effect of the downturn: while there was a small reduction in all-cause mortality during this crisis, only those reductions in heart disease (small) and traffic fatalities (rather larger) could plausibly be linked to contemporaneous local economic shocks; other recession-related causes of death identified in the literature, such as suicide, rose substantially. Fishback et al. (2007) similarly find that had New Deal relief spending not intervened, the Great Depression would have created a “demographic disaster,” depressing birth rates and elevating death rates relative to prior trends (particularly among infants, those perhaps most vulnerable to short-run income fluctuations). Their results emphasize the importance of government responses to economic crises that in turn become health crises (and vice-versa): for instance, they note that while all-cause non-infant mortality rates were largely unaffected by relief spending, such income support nevertheless did help reduce rates of certain salient causes of death such as suicide, one of the few causes of adult mortality identified in Stuckler et al. (2012) as seeing a marked increase during the Great Depression.

The long-run scarring effects of recessions

While current debates around COVID-19 are understandably focused on the immediate impact of pandemic-induced recession conditions, the economic history literature teaches us that we should be equally—perhaps even more—concerned about the long-run scarring effects arising from this economic dislocation. Indeed, this channel may be especially relevant in more modern, high-income, and robust-safety net settings where most people survive an adverse shock, only to contend with the long-term and sometimes latent fallout. Some of these scarring effects stem from the immediate impact on household incomes. Depression-era resource deficits have been shown to affect cohorts that were in utero at the time well into adulthood, lowering their college completion rates and later-life incomes, and raising their rates of later-life poverty and disability—adverse effects that were only more pronounced in poorer areas, and areas that received less relief spending (Arthi, 2018; Fishback and Thomasson, 2014).51 Meanwhile, other long-run penalties arise from disruptions to labor markets and human capital acquisition. A large contemporary literature studies the phenomenon of labor market scarring, or the idea that economic conditions at the time of labor market entry may have lasting effects on training decisions, occupational choice, career trajectories, and lifetime income.52 This evidence, much of it taken from college graduates around the 2008 Recession, is mixed: some studies suggest that the impact of initial labor market conditions diminishes over the course of an individual's career—often within the first decade—while others find that some penalties associated with early-career shocks can be cumulative and permanent (see Rothstein (2019) for an in-depth review; see also, Kahn (2010)). These effects are often heterogeneous by skill level, and may be driven by mismatch in initial job placement (Faberman and Mazumder 2012, Liu et al. 2016, Oyer, 2008, Şahin et al. 2014, van den Berge 2018), lower initial wages (which may be partially related to job mismatch; Oreopoulos, Philip, Till von Wachter, and Andrew Heisz, 2012), reduced working time (Cockx and Ghirelli 2016), and delays in finding employment (Genda et al. 2010), among other factors. Moreover, strategic responses to these shocks, such as migration (Feigenbaum 2015), temporary exit from the labor force (Hershbein 2012), and human capital acquisition (Charles et al. 2018, Barr and Turner 2015), may themselves have implications for short- and long-run labor market prospects, as separate from those arising directly from the initial shock.53 These studies thus strongly suggest that downturns may have important “overhang” that may potentially “reduce prosperity for decades to come,” both for directly-affected cohorts and the wider economy (Rothstein 2019, p. 4). Accordingly—and bearing in mind that under COVID-19, peak unemployment rates for younger workers have been nearly three times the national average54 —very-long-run and even intergenerational evidence on these issues can be especially valuable. Recent work in economic history has looked to the Great Depression in order to offer precisely this sort of perspective. These studies show substantial and persistent penalties for all workers in severely-hit areas, but especially for new labor market entrants, who faced very different constraints and scope for adaptation than did incumbent workers. Moulton (2017), for instance, finds a substantial earnings penalty amongst less-educated American men just entering the labor market in 1930. While there are large adverse effects for those born in severely-affected states, this age-at-downturn penalty disappears in less-affected states. Likewise, examining evidence on labor force transitions using large-scale linked microdata from the U.S., Arthi et al. (2020b) show that many younger workers during the Depression accepted work that they otherwise might not have considered in better economic times—whether because of their now-dire need, the additional competition from older workers, or some combination of these factors. Moreover, many young people seeking work were locked out of the labor market completely by their older counterparts, who now remained in the labor force (or even re-entered it) at higher rates. Evidence on occupational transitions and socioeconomic mobility also suggest important career-stage gradients in scarring: younger workers were crowded out of the best local job opportunities by their older counterparts, with young workers in more rural areas pushed out of farming by older workers who retained these jobs at higher rates, and into general laborer and non-occupational positions; and those in more industrial areas being pushed into farming, the less desirable class of occupations in these areas. Importantly, while both of these outcomes represent a short-run penalty for newer labor market entrants, the long-run implications for wellbeing may be very different, given the rapid urbanization and the incipient decline of the agricultural sector that was to come. Indeed, by providing the impetus to leave agriculture (or by prompting higher rates of out-migration—younger labor market cohorts irrespective of sector were also likelier to have moved across state lines or into urban areas during the Depression, perhaps in response to the dearth of local opportunities for inexperienced workers), the Great Depression may have had a small silver lining for young rural workers. However, at least in the short run, it served to hamper upward income mobility—or even, to induce downward mobility. For instance, Liu and Fishback (2019) show that though concerns over skill depreciation and mismatch during spells of un- or under-employment animated Depression-era policymakers, New Deal programs largely failed to match workers to jobs that used their skills, often resulting in lower incomes and transitions into lower-skilled employment or unemployment—though at least some general human capital was maintained. Meanwhile, Feigenbaum (2015) finds that by 1940, intergenerational mobility had fallen for men growing up in cities severely hit by the Depression. Migration—in particular, the superior destination choices of the sons of richer fathers—was an important mechanism behind these results, again emphasizing the capacity of large adverse shocks to exacerbate rather than level preexisting inequalities.

Moving forward

The history of past pandemics and economic downturns provides sobering guidance for what we might expect from the current COVID-19 crisis. There is a complicated relationship between health and economic productivity that will shape the immediate and latent effects of COVID-19 in both obvious and subtle ways. Given that these latent effects unfold over decades and even generations, economic history is uniquely capable of providing evidence on the potential long-term costs of the pandemic. Experience from both historical pandemics and historical recessions can inform our view of the possible long-run effects of COVID-19, and how we might mitigate these costs. The experience of the 1918 influenza pandemic suggests that disease exposure can impact individuals throughout their lifetimes, both directly through poorer ongoing health, and indirectly through reduced investment in human capital. The costs were not limited to those individuals directly exposed; instead, they spilled over within households and across space, sectors and generations. Moreover, while mortality is salient, and the saving of lives remains perhaps the primary objective during a pandemic, avoiding and compensating for morbidity is arguably as important a matter of policy concern, especially in the context of possible long-run effects. Particularly in a pandemic where large shares of prime-aged people fall ill (as in the 1918 pandemic), or in pandemics where many are infected but ultimately survive (as in both the 1918 pandemic and COVID-19), experiences of pandemic illness may have lasting effects over the life-course, either through the initial illness (which may, for instance, compromise fetal nutrition, reduce work capacity, or permanently damage health), or through its sequelae later in life. The Great Depression points to other long-term effects that are likely to emerge from the pandemic-related slowdown in economic activity: both being born or entering the labor market during the Great Depression led to economic penalties well into adulthood, and constraints on migration had adverse effects on individuals and firms. Importantly, history shows us that these two types of harms are mutually reinforcing: damage to health tends to undermine labor market prospects in the long run, while damage to labor market prospects tends to undermine health in the long run. Researchers and policymakers should therefore consider the potential for these long-run costs when weighing the short-term costs and benefits of pandemic control and fiscal intervention. History suggests potentially massive future costs for both the economy and the safety net arising from the dampened economic fortunes, chronic health issues, and foregone fertility of cohorts impacted by COVID-19. Given that human capital investments are generally more productive the earlier they are implemented, this suggests that policy interventions undertaken now, such as cash relief, could be especially cost-effective, and their net long-run benefits tremendous. Economic history also reveals that we cannot think of the health and economic impacts of COVID-19 independently of one another. Past pandemics indicate that regardless of the pathology of a disease, its impacts are often a function of economic conditions. While some pandemics spared no class, many disproportionately impacted individuals of lower socioeconomic status due to a variety of factors including their occupations, living conditions, and access to healthcare. These individuals are at greater risk of exposure, face greater harms conditional on exposure, and are less able to remediate these harms. We have already seen this taking place with COVID-19, and need to remain aware that the spread of the disease and the severity of its effects will be in part a function of the spatial distribution of residence, economic activity, and environmental harms. These disparate impacts of the virus itself will be compounded by the associated economic downturn. To the extent that the COVID-19 economic downturn limits exposure to environmental and work-related hazards, or reduces spending on unhealthy behaviors, non-coronavirus related dimensions of health may actually improve. However, both the modern literature on developing countries and the U.S.’s experience during the Great Depression suggest that the severe economic downturn may compound health problems in areas with lower baseline incomes and weaker safety nets. Identifying the channels through which income loss and general recession conditions impact health is necessary for properly interpreting any observed changes in population health levels during COVID-19, and for designing effective policies to safeguard health. Successful implementation of these policies also requires a firm understanding of history. In particular, those roadblocks to public health initiatives during past pandemics that were associated with institutional structures and individual attitudes offer cautionary tales for our current crisis. While economic history provides useful insights for the current pandemic, the way in which this crisis is unfolding also provides a fresh perspective with which to revisit the past. We are witnessing the actions that individuals and families, workers and firms, citizens and public officials alike, take to guard against the pandemic, and the damage it has done to the economy. We are witnessing how these responses change as new information on COVID-19 emerges. The current pandemic affords us unprecedently rich and disaggregated data that, even while still evolving, can give new insights into which groups might warrant additional study in past pandemics. All of these dimensions of COVID-19 can help us reshape the roadmap for studying the economic history of pandemics. One of the most important ways the COVID-19 experience can shape the direction of economic history may not be in seeking out the similarities but rather in focusing on differences. While the rate of transmission and severity of the effects of COVID-19 have historical analogues, many relevant features of the world are meaningfully different—among them, the global nature of production; flows of people, goods, and information; urbanization; baseline living standards; medical technology; public health infrastructure; and the role of government. These differences can help us understand both past and present pandemics better; moreover, they help us understand how and why things have changed. For example, the COVID-19 shutdowns have been more far-reaching, and the corresponding economic downturn more damaging, than we might have predicted from previous pandemics. Can these differences explain the far greater economic costs of COVID-19 relative to similarly lethal pandemics of the 20th century? This suggests an important direction for future economic history work: identifying why the nature of the response to public health crises differed, and why the resulting economic consequences were often smaller historically. Engaging in this work also allows us to grapple with challenging questions about tradeoffs between population health and economic activity. These tradeoffs are incredibly difficult to tackle head on in the face of an unfolding crisis; they force unfathomable but unavoidable choices on policymakers often working with limited information. By offering insight into not just the actions but also the short- and long-run outcomes of governments, firms, and individuals, economic history can guide us to better decisions in this and future crises.
  51 in total

1.  A socially neutral disease? Individual social class, household wealth and mortality from Spanish influenza in two socially contrasting parishes in Kristiania 1918-19.

Authors:  Svenn-Erik Mamelund
Journal:  Soc Sci Med       Date:  2005-08-08       Impact factor: 4.634

2.  The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: an age, period, cohort analysis.

Authors:  Andrew Noymer
Journal:  Vaccine       Date:  2011-07-22       Impact factor: 3.641

3.  Malaria Eradication in the Americas: A Retrospective Analysis of Childhood Exposure.

Authors:  Hoyt Bleakley
Journal:  Am Econ J Appl Econ       Date:  2010-04

4.  Reply to Shanks and Brundage: Many plausible mechanisms of pandemic mortality disparities.

Authors:  Kyra H Grantz; Madhura S Rane; Henrik Salje; Gregory E Glass; Stephen E Schachterle; Derek A T Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-06       Impact factor: 11.205

5.  The long-run effects of pandemic influenza on the development of children from elite backgrounds: Evidence from industrializing Japan.

Authors:  Kota Ogasawara
Journal:  Econ Hum Biol       Date:  2018-09-01       Impact factor: 2.184

6.  Business recession, alcohol consumption, drinking and driving laws: impact on Oklahoma motor vehicle fatalities and fatal crashes.

Authors:  A Muller
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

Review 7.  Smallpox: gone but not forgotten.

Authors:  P D Ellner
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

8.  Graduating High School in a Recession: Work, Education, and Home Production.

Authors:  Brad J Hershbein
Journal:  B E J Econom Anal Policy       Date:  2012-01-31

9.  COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020.

Authors:  Jonathan W Dyal; Michael P Grant; Kendra Broadwater; Adam Bjork; Michelle A Waltenburg; John D Gibbins; Christa Hale; Maggie Silver; Marc Fischer; Jonathan Steinberg; Colin A Basler; Jesica R Jacobs; Erin D Kennedy; Suzanne Tomasi; Douglas Trout; Jennifer Hornsby-Myers; Nadia L Oussayef; Lisa J Delaney; Ketki Patel; Varun Shetty; Kelly E Kline; Betsy Schroeder; Rachel K Herlihy; Jennifer House; Rachel Jervis; Joshua L Clayton; Dustin Ortbahn; Connie Austin; Erica Berl; Zack Moore; Bryan F Buss; Derry Stover; Ryan Westergaard; Ian Pray; Meghan DeBolt; Amy Person; Julie Gabel; Theresa S Kittle; Pamela Hendren; Charles Rhea; Caroline Holsinger; John Dunn; George Turabelidze; Farah S Ahmed; Siestke deFijter; Caitlin S Pedati; Karyl Rattay; Erica E Smith; Carolina Luna-Pinto; Laura A Cooley; Sharon Saydah; Nykiconia D Preacely; Ryan A Maddox; Elizabeth Lundeen; Bradley Goodwin; Sandor E Karpathy; Sean Griffing; Mary M Jenkins; Garry Lowry; Rachel D Schwarz; Jonathan Yoder; Georgina Peacock; Henry T Walke; Dale A Rose; Margaret A Honein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-08       Impact factor: 17.586

10.  Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020.

Authors:  Austan Goolsbee; Chad Syverson
Journal:  J Public Econ       Date:  2020-11-25
View more
  13 in total

1.  Adolescents' psychosocial well-being one year after the outbreak of the COVID-19 pandemic in Norway.

Authors:  Tilmann von Soest; Michal Kozák; Rubén Rodríguez-Cano; Dirkje H Fluit; Laura Cortés-García; Vidar S Ulset; E F Haghish; Anders Bakken
Journal:  Nat Hum Behav       Date:  2022-01-20

2.  Women's health: A revised global agenda in the COVID-19 era?

Authors:  Ali Mobasheri
Journal:  Case Rep Womens Health       Date:  2021-02-05

Review 3.  Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility.

Authors:  Caterina Vicidomini; Valentina Roviello; Giovanni N Roviello
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

Review 4.  Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review.

Authors:  Windi Fresha Qomara; Delya Nur Primanissa; Salma Hasni Amalia; Febby V Purwadi; Neily Zakiyah
Journal:  Int J Gen Med       Date:  2021-11-23

Review 5.  Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.

Authors:  Jitendra Kumar Chaudhary; Rohitash Yadav; Pankaj Kumar Chaudhary; Anurag Maurya; Nimita Kant; Osamah Al Rugaie; Hoineiting Rebecca Haokip; Deepika Yadav; Rakesh Roshan; Ramasare Prasad; Apurva Chatrath; Dharmendra Singh; Neeraj Jain; Puneet Dhamija
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

Review 6.  Aspirin in COVID-19: Pros and Cons.

Authors:  Rana Zareef; Marwa Diab; Tala Al Saleh; Adham Makarem; Nour K Younis; Fadi Bitar; Mariam Arabi
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

7.  The COVID-19 pandemic reshapes the plastic pollution research - A comparative analysis of plastic pollution research before and during the pandemic.

Authors:  Qiang Wang; Min Zhang; Rongrong Li
Journal:  Environ Res       Date:  2021-12-29       Impact factor: 8.431

8.  The economics of epidemics and contagious diseases: An introduction.

Authors:  Raouf Boucekkine; Andrés Carvajal; Shankha Chakraborty; Aditya Goenka
Journal:  J Math Econ       Date:  2021-02-18       Impact factor: 0.725

9.  Flattening the quality of life curve? A prospective person-centred study from Norway amid COVID-19.

Authors:  Ragnhild Bang Nes; Baeksan Yu; Thomas Hansen; Øystein Vedaa; Espen Røysamb; Thomas S Nilsen
Journal:  Qual Life Res       Date:  2022-03-24       Impact factor: 4.147

10.  The association of COVID-19 employment shocks with suicide and safety net use: An early-stage investigation.

Authors:  Michihito Ando; Masato Furuichi
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.